Tuberculosis in the Circumpolar Region, 2006-2012
SETTING: The northern circumpolar jurisdictions Canada (Northwest Territories, Nunavik, Nunavut, Yukon), Finland, Greenland, Norway, Russian Federation (Arkhangelsk), Sweden and the United States (Alaska).OBJECTIVE: To describe and compare demographic, clinical and laboratory characteristics, includ...
Gespeichert in:
| Veröffentlicht in: | The international journal of tuberculosis and lung disease 2018-06, Vol.22 (6), p.641-648 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 648 |
|---|---|
| container_issue | 6 |
| container_start_page | 641 |
| container_title | The international journal of tuberculosis and lung disease |
| container_volume | 22 |
| creator | Bourgeois, A-C. Zulz, T. Bruce, M. G. Stenz, F. Koch, A. Parkinson, A. Hennessy, T. Cooper, M. Newberry, C. Randell, E. Proulx, J-F. Hanley, B. E. Soini, H. Arnesen, T. M. Mariandyshev, A. Jonsson, J. Søborg, B. Wolfe, J. Balancev, G. Bruun de Neergaard, R. Archibald, C. P. |
| description | SETTING: The northern circumpolar jurisdictions Canada (Northwest Territories, Nunavik, Nunavut, Yukon), Finland, Greenland, Norway, Russian Federation (Arkhangelsk), Sweden and the United States (Alaska).OBJECTIVE: To describe and compare demographic, clinical and laboratory characteristics,
including drug resistance and treatment completion, of tuberculosis (TB) cases in the northern circumpolar populations.DESIGN: Descriptive analysis of all active TB cases reported from 2006 to 2012 for incidence rate (IR), age and sex distribution, sputum smear and diagnostic site characteristics,
drug resistance and treatment completion rates.RESULTS: The annual IR of TB disease ranged from a low of 4.3 per 100 000 population in Northern Sweden to a high of 199.5/100 000 in Nunavik, QC, Canada. For all jurisdictions, IR was higher for males than for females. Yukon
had the highest proportion of new cases compared with retreatment cases (96.6%). Alaska reported the highest percentage of laboratory-confirmed cases (87.4%). Smear-positive pulmonary cases ranged from 25.8% to 65.2%. Multidrug-resistant cases ranged from 0% (Northern Canada) to 46.3% (Arkhangelsk).
Treatment outcome data, available up to 2011, demonstrated >80% treatment completion for four of the 10 jurisdictions.CONCLUSION: TB remains a serious public health issue in the circumpolar regions. Surveillance data contribute toward a better understanding and improved control of TB
in the north. |
| doi_str_mv | 10.5588/ijtld.17.0525 |
| format | Article |
| fullrecord | <record><control><sourceid>pubtec_proqu</sourceid><recordid>TN_cdi_proquest_journals_2037242678</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ingid>iuatld/ijtld/2018/00000022/00000006/art00012</ingid><sourcerecordid>iuatld/ijtld/2018/00000022/00000006/art00012</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-a0eafb9985b8093cf8edec936099f04a02d543d73afe8d942073f887499960ca3</originalsourceid><addsrcrecordid>eNp1kU1r3DAQhkVJaT7aY6_BkEsP9XY0sr6OYdOmhUBpSc-D1pY3Wrz2RrIL7a-vdr1NoFBdZhgeHg3vMPaWw0JKYz6Ezdg1C64XIFG-YGfccFlqi3CSe0BdCs3tKTtPaQOAnHP9ip2iNQptZc4Yv59WPtZTN6SQitAX44MvliFPtruhc7H47tdh6N8XCKBKBI6v2cvWdcm_OdYL9uPTx_vl5_Lu6-2X5fVdWVdSjaUD79qVtUauDFhRt8Y3vrZCgbUtVA6wkZVotHCtN42tELRojdGVtVZB7cQFezd7d3F4nHwaaRtS7bvO9X6YEiFkVKC0KqNX_6CbYYp93i5TQmOFSptMlTNVxyGl6FvaxbB18RdxoH2WdMiSuKZ9lpm_PFqn1dY3T_Tf8DLwbQZCv_b96J5_DTWFyR1k-QT7C9BPxF7ldZCDQUlcgqbGt27qRhpdpPVvShyz8-Z_zlk475gPYQgOD_HYgCIXx1yz5g9nZp1d</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2037242678</pqid></control><display><type>article</type><title>Tuberculosis in the Circumpolar Region, 2006-2012</title><source>PubMed (Medline)</source><source>Alma/SFX Local Collection</source><creator>Bourgeois, A-C. ; Zulz, T. ; Bruce, M. G. ; Stenz, F. ; Koch, A. ; Parkinson, A. ; Hennessy, T. ; Cooper, M. ; Newberry, C. ; Randell, E. ; Proulx, J-F. ; Hanley, B. E. ; Soini, H. ; Arnesen, T. M. ; Mariandyshev, A. ; Jonsson, J. ; Søborg, B. ; Wolfe, J. ; Balancev, G. ; Bruun de Neergaard, R. ; Archibald, C. P.</creator><creatorcontrib>Bourgeois, A-C. ; Zulz, T. ; Bruce, M. G. ; Stenz, F. ; Koch, A. ; Parkinson, A. ; Hennessy, T. ; Cooper, M. ; Newberry, C. ; Randell, E. ; Proulx, J-F. ; Hanley, B. E. ; Soini, H. ; Arnesen, T. M. ; Mariandyshev, A. ; Jonsson, J. ; Søborg, B. ; Wolfe, J. ; Balancev, G. ; Bruun de Neergaard, R. ; Archibald, C. P.</creatorcontrib><description>SETTING: The northern circumpolar jurisdictions Canada (Northwest Territories, Nunavik, Nunavut, Yukon), Finland, Greenland, Norway, Russian Federation (Arkhangelsk), Sweden and the United States (Alaska).OBJECTIVE: To describe and compare demographic, clinical and laboratory characteristics,
including drug resistance and treatment completion, of tuberculosis (TB) cases in the northern circumpolar populations.DESIGN: Descriptive analysis of all active TB cases reported from 2006 to 2012 for incidence rate (IR), age and sex distribution, sputum smear and diagnostic site characteristics,
drug resistance and treatment completion rates.RESULTS: The annual IR of TB disease ranged from a low of 4.3 per 100 000 population in Northern Sweden to a high of 199.5/100 000 in Nunavik, QC, Canada. For all jurisdictions, IR was higher for males than for females. Yukon
had the highest proportion of new cases compared with retreatment cases (96.6%). Alaska reported the highest percentage of laboratory-confirmed cases (87.4%). Smear-positive pulmonary cases ranged from 25.8% to 65.2%. Multidrug-resistant cases ranged from 0% (Northern Canada) to 46.3% (Arkhangelsk).
Treatment outcome data, available up to 2011, demonstrated >80% treatment completion for four of the 10 jurisdictions.CONCLUSION: TB remains a serious public health issue in the circumpolar regions. Surveillance data contribute toward a better understanding and improved control of TB
in the north.</description><identifier>ISSN: 1027-3719</identifier><identifier>EISSN: 1815-7920</identifier><identifier>DOI: 10.5588/ijtld.17.0525</identifier><identifier>PMID: 29862948</identifier><language>eng</language><publisher>France: International Union Against Tuberculosis and Lung Disease</publisher><subject>Age composition ; Arctic ; Demographics ; Diagnostic systems ; Drug resistance ; Epidemiology ; Females ; Laboratories ; Males ; Multidrug resistance ; Northern ; Public health ; Smear ; Sputum ; Surveillance ; Treatment ; Tuberculosis</subject><ispartof>The international journal of tuberculosis and lung disease, 2018-06, Vol.22 (6), p.641-648</ispartof><rights>Copyright International Union against Tuberculosis and Lung Disease (IUATLD) Jun 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-a0eafb9985b8093cf8edec936099f04a02d543d73afe8d942073f887499960ca3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29862948$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bourgeois, A-C.</creatorcontrib><creatorcontrib>Zulz, T.</creatorcontrib><creatorcontrib>Bruce, M. G.</creatorcontrib><creatorcontrib>Stenz, F.</creatorcontrib><creatorcontrib>Koch, A.</creatorcontrib><creatorcontrib>Parkinson, A.</creatorcontrib><creatorcontrib>Hennessy, T.</creatorcontrib><creatorcontrib>Cooper, M.</creatorcontrib><creatorcontrib>Newberry, C.</creatorcontrib><creatorcontrib>Randell, E.</creatorcontrib><creatorcontrib>Proulx, J-F.</creatorcontrib><creatorcontrib>Hanley, B. E.</creatorcontrib><creatorcontrib>Soini, H.</creatorcontrib><creatorcontrib>Arnesen, T. M.</creatorcontrib><creatorcontrib>Mariandyshev, A.</creatorcontrib><creatorcontrib>Jonsson, J.</creatorcontrib><creatorcontrib>Søborg, B.</creatorcontrib><creatorcontrib>Wolfe, J.</creatorcontrib><creatorcontrib>Balancev, G.</creatorcontrib><creatorcontrib>Bruun de Neergaard, R.</creatorcontrib><creatorcontrib>Archibald, C. P.</creatorcontrib><title>Tuberculosis in the Circumpolar Region, 2006-2012</title><title>The international journal of tuberculosis and lung disease</title><addtitle>Int J Tuberc Lung Dis</addtitle><description>SETTING: The northern circumpolar jurisdictions Canada (Northwest Territories, Nunavik, Nunavut, Yukon), Finland, Greenland, Norway, Russian Federation (Arkhangelsk), Sweden and the United States (Alaska).OBJECTIVE: To describe and compare demographic, clinical and laboratory characteristics,
including drug resistance and treatment completion, of tuberculosis (TB) cases in the northern circumpolar populations.DESIGN: Descriptive analysis of all active TB cases reported from 2006 to 2012 for incidence rate (IR), age and sex distribution, sputum smear and diagnostic site characteristics,
drug resistance and treatment completion rates.RESULTS: The annual IR of TB disease ranged from a low of 4.3 per 100 000 population in Northern Sweden to a high of 199.5/100 000 in Nunavik, QC, Canada. For all jurisdictions, IR was higher for males than for females. Yukon
had the highest proportion of new cases compared with retreatment cases (96.6%). Alaska reported the highest percentage of laboratory-confirmed cases (87.4%). Smear-positive pulmonary cases ranged from 25.8% to 65.2%. Multidrug-resistant cases ranged from 0% (Northern Canada) to 46.3% (Arkhangelsk).
Treatment outcome data, available up to 2011, demonstrated >80% treatment completion for four of the 10 jurisdictions.CONCLUSION: TB remains a serious public health issue in the circumpolar regions. Surveillance data contribute toward a better understanding and improved control of TB
in the north.</description><subject>Age composition</subject><subject>Arctic</subject><subject>Demographics</subject><subject>Diagnostic systems</subject><subject>Drug resistance</subject><subject>Epidemiology</subject><subject>Females</subject><subject>Laboratories</subject><subject>Males</subject><subject>Multidrug resistance</subject><subject>Northern</subject><subject>Public health</subject><subject>Smear</subject><subject>Sputum</subject><subject>Surveillance</subject><subject>Treatment</subject><subject>Tuberculosis</subject><issn>1027-3719</issn><issn>1815-7920</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kU1r3DAQhkVJaT7aY6_BkEsP9XY0sr6OYdOmhUBpSc-D1pY3Wrz2RrIL7a-vdr1NoFBdZhgeHg3vMPaWw0JKYz6Ezdg1C64XIFG-YGfccFlqi3CSe0BdCs3tKTtPaQOAnHP9ip2iNQptZc4Yv59WPtZTN6SQitAX44MvliFPtruhc7H47tdh6N8XCKBKBI6v2cvWdcm_OdYL9uPTx_vl5_Lu6-2X5fVdWVdSjaUD79qVtUauDFhRt8Y3vrZCgbUtVA6wkZVotHCtN42tELRojdGVtVZB7cQFezd7d3F4nHwaaRtS7bvO9X6YEiFkVKC0KqNX_6CbYYp93i5TQmOFSptMlTNVxyGl6FvaxbB18RdxoH2WdMiSuKZ9lpm_PFqn1dY3T_Tf8DLwbQZCv_b96J5_DTWFyR1k-QT7C9BPxF7ldZCDQUlcgqbGt27qRhpdpPVvShyz8-Z_zlk475gPYQgOD_HYgCIXx1yz5g9nZp1d</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Bourgeois, A-C.</creator><creator>Zulz, T.</creator><creator>Bruce, M. G.</creator><creator>Stenz, F.</creator><creator>Koch, A.</creator><creator>Parkinson, A.</creator><creator>Hennessy, T.</creator><creator>Cooper, M.</creator><creator>Newberry, C.</creator><creator>Randell, E.</creator><creator>Proulx, J-F.</creator><creator>Hanley, B. E.</creator><creator>Soini, H.</creator><creator>Arnesen, T. M.</creator><creator>Mariandyshev, A.</creator><creator>Jonsson, J.</creator><creator>Søborg, B.</creator><creator>Wolfe, J.</creator><creator>Balancev, G.</creator><creator>Bruun de Neergaard, R.</creator><creator>Archibald, C. P.</creator><general>International Union Against Tuberculosis and Lung Disease</general><general>International Union against Tuberculosis and Lung Disease (IUATLD)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20180601</creationdate><title>Tuberculosis in the Circumpolar Region, 2006-2012</title><author>Bourgeois, A-C. ; Zulz, T. ; Bruce, M. G. ; Stenz, F. ; Koch, A. ; Parkinson, A. ; Hennessy, T. ; Cooper, M. ; Newberry, C. ; Randell, E. ; Proulx, J-F. ; Hanley, B. E. ; Soini, H. ; Arnesen, T. M. ; Mariandyshev, A. ; Jonsson, J. ; Søborg, B. ; Wolfe, J. ; Balancev, G. ; Bruun de Neergaard, R. ; Archibald, C. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-a0eafb9985b8093cf8edec936099f04a02d543d73afe8d942073f887499960ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Age composition</topic><topic>Arctic</topic><topic>Demographics</topic><topic>Diagnostic systems</topic><topic>Drug resistance</topic><topic>Epidemiology</topic><topic>Females</topic><topic>Laboratories</topic><topic>Males</topic><topic>Multidrug resistance</topic><topic>Northern</topic><topic>Public health</topic><topic>Smear</topic><topic>Sputum</topic><topic>Surveillance</topic><topic>Treatment</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bourgeois, A-C.</creatorcontrib><creatorcontrib>Zulz, T.</creatorcontrib><creatorcontrib>Bruce, M. G.</creatorcontrib><creatorcontrib>Stenz, F.</creatorcontrib><creatorcontrib>Koch, A.</creatorcontrib><creatorcontrib>Parkinson, A.</creatorcontrib><creatorcontrib>Hennessy, T.</creatorcontrib><creatorcontrib>Cooper, M.</creatorcontrib><creatorcontrib>Newberry, C.</creatorcontrib><creatorcontrib>Randell, E.</creatorcontrib><creatorcontrib>Proulx, J-F.</creatorcontrib><creatorcontrib>Hanley, B. E.</creatorcontrib><creatorcontrib>Soini, H.</creatorcontrib><creatorcontrib>Arnesen, T. M.</creatorcontrib><creatorcontrib>Mariandyshev, A.</creatorcontrib><creatorcontrib>Jonsson, J.</creatorcontrib><creatorcontrib>Søborg, B.</creatorcontrib><creatorcontrib>Wolfe, J.</creatorcontrib><creatorcontrib>Balancev, G.</creatorcontrib><creatorcontrib>Bruun de Neergaard, R.</creatorcontrib><creatorcontrib>Archibald, C. P.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The international journal of tuberculosis and lung disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bourgeois, A-C.</au><au>Zulz, T.</au><au>Bruce, M. G.</au><au>Stenz, F.</au><au>Koch, A.</au><au>Parkinson, A.</au><au>Hennessy, T.</au><au>Cooper, M.</au><au>Newberry, C.</au><au>Randell, E.</au><au>Proulx, J-F.</au><au>Hanley, B. E.</au><au>Soini, H.</au><au>Arnesen, T. M.</au><au>Mariandyshev, A.</au><au>Jonsson, J.</au><au>Søborg, B.</au><au>Wolfe, J.</au><au>Balancev, G.</au><au>Bruun de Neergaard, R.</au><au>Archibald, C. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tuberculosis in the Circumpolar Region, 2006-2012</atitle><jtitle>The international journal of tuberculosis and lung disease</jtitle><addtitle>Int J Tuberc Lung Dis</addtitle><date>2018-06-01</date><risdate>2018</risdate><volume>22</volume><issue>6</issue><spage>641</spage><epage>648</epage><pages>641-648</pages><issn>1027-3719</issn><eissn>1815-7920</eissn><abstract>SETTING: The northern circumpolar jurisdictions Canada (Northwest Territories, Nunavik, Nunavut, Yukon), Finland, Greenland, Norway, Russian Federation (Arkhangelsk), Sweden and the United States (Alaska).OBJECTIVE: To describe and compare demographic, clinical and laboratory characteristics,
including drug resistance and treatment completion, of tuberculosis (TB) cases in the northern circumpolar populations.DESIGN: Descriptive analysis of all active TB cases reported from 2006 to 2012 for incidence rate (IR), age and sex distribution, sputum smear and diagnostic site characteristics,
drug resistance and treatment completion rates.RESULTS: The annual IR of TB disease ranged from a low of 4.3 per 100 000 population in Northern Sweden to a high of 199.5/100 000 in Nunavik, QC, Canada. For all jurisdictions, IR was higher for males than for females. Yukon
had the highest proportion of new cases compared with retreatment cases (96.6%). Alaska reported the highest percentage of laboratory-confirmed cases (87.4%). Smear-positive pulmonary cases ranged from 25.8% to 65.2%. Multidrug-resistant cases ranged from 0% (Northern Canada) to 46.3% (Arkhangelsk).
Treatment outcome data, available up to 2011, demonstrated >80% treatment completion for four of the 10 jurisdictions.CONCLUSION: TB remains a serious public health issue in the circumpolar regions. Surveillance data contribute toward a better understanding and improved control of TB
in the north.</abstract><cop>France</cop><pub>International Union Against Tuberculosis and Lung Disease</pub><pmid>29862948</pmid><doi>10.5588/ijtld.17.0525</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1027-3719 |
| ispartof | The international journal of tuberculosis and lung disease, 2018-06, Vol.22 (6), p.641-648 |
| issn | 1027-3719 1815-7920 |
| language | eng |
| recordid | cdi_proquest_journals_2037242678 |
| source | PubMed (Medline); Alma/SFX Local Collection |
| subjects | Age composition Arctic Demographics Diagnostic systems Drug resistance Epidemiology Females Laboratories Males Multidrug resistance Northern Public health Smear Sputum Surveillance Treatment Tuberculosis |
| title | Tuberculosis in the Circumpolar Region, 2006-2012 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T19%3A40%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubtec_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tuberculosis%20in%20the%20Circumpolar%20Region,%202006-2012&rft.jtitle=The%20international%20journal%20of%20tuberculosis%20and%20lung%20disease&rft.au=Bourgeois,%20A-C.&rft.date=2018-06-01&rft.volume=22&rft.issue=6&rft.spage=641&rft.epage=648&rft.pages=641-648&rft.issn=1027-3719&rft.eissn=1815-7920&rft_id=info:doi/10.5588/ijtld.17.0525&rft_dat=%3Cpubtec_proqu%3Eiuatld/ijtld/2018/00000022/00000006/art00012%3C/pubtec_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2037242678&rft_id=info:pmid/29862948&rft_ingid=iuatld/ijtld/2018/00000022/00000006/art00012&rfr_iscdi=true |